These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 28531208
1. Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing. Demczuk WHB, Martin I, Hoang L, Van Caeseele P, Lefebvre B, Horsman G, Haldane D, Gubbay J, Ratnam S, German G, Daley Bernier J, Strudwick L, McGeer A, Zhanel GG, Van Domselaar G, Graham M, Mulvey MR. PLoS One; 2017; 12(5):e0178040. PubMed ID: 28531208 [Abstract] [Full Text] [Related]
2. Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13. Golden AR, Adam HJ, Gilmour MW, Baxter MR, Martin I, Nichol KA, Demczuk WH, Hoban DJ, Zhanel GG. J Antimicrob Chemother; 2015 Jul; 70(7):1960-4. PubMed ID: 25761605 [Abstract] [Full Text] [Related]
3. Population structure and drug resistance patterns of emerging non-PCV-13 Streptococcus pneumoniae serotypes 22F, 15A, and 8 isolated from adults in Ontario, Canada. Duvvuri VR, Deng X, Teatero S, Memari N, Athey T, Fittipaldi N, Gubbay JB. Infect Genet Evol; 2016 Aug; 42():1-8. PubMed ID: 27071529 [Abstract] [Full Text] [Related]
4. Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F. Golden AR, Adam HJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA). Vaccine; 2016 May 17; 34(23):2527-30. PubMed ID: 27085174 [Abstract] [Full Text] [Related]
5. PCR-based discrimination of emerging Streptococcus pneumoniae serotypes 22F and 33F. Gillis HD, Demczuk WHB, Griffith A, Martin I, Warhuus M, Lang ALS, ElSherif M, McNeil SA, LeBlanc JJ. J Microbiol Methods; 2018 Jan 17; 144():99-106. PubMed ID: 29162393 [Abstract] [Full Text] [Related]
6. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014. Nakano S, Fujisawa T, Ito Y, Chang B, Suga S, Noguchi T, Yamamoto M, Matsumura Y, Nagao M, Takakura S, Ohnishi M, Ihara T, Ichiyama S. Vaccine; 2016 Jan 02; 34(1):67-76. PubMed ID: 26602268 [Abstract] [Full Text] [Related]
7. Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: Focus on serotypes 22F and 33F from CANWARD 2007-2018. Golden AR, Adam HJ, Baxter M, Martin I, Demczuk W, Mulvey MR, Karlowsky JA, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA). Vaccine; 2021 Sep 15; 39(39):5474-5483. PubMed ID: 34454785 [Abstract] [Full Text] [Related]
8. Genetic analysis of invasive pneumococcal isolates from children in Ontario, Canada, 2007-2012. Deng X, Arya G, Memari N, Mackenzie R, MacMullin G, Low DE, Pillai DR, Gubbay JB. Pediatr Infect Dis J; 2015 Jun 15; 34(6):594-8. PubMed ID: 25831418 [Abstract] [Full Text] [Related]
9. [Streptococcus pneumoniae serotypes 8 and 22F causing invasive pneumococcal disease in the Czech Republic in 2014-2020: whole genome sequencing (WGS) analysis]. Kozáková J, Vohrnová S, Honskus M, Křížová P. Epidemiol Mikrobiol Imunol; 2024 Jun 15; 73(2):84-97. PubMed ID: 39060099 [Abstract] [Full Text] [Related]
10. Population structure of invasive Streptococcus pneumoniae isolates among Alaskan children in the conjugate vaccine era, 2001 to 2013. Miernyk KM, Bulkow LR, Case SL, Zulz T, Bruce MG, Harker-Jones M, Hurlburt DA, Hennessy TW, Rudolph KM. Diagn Microbiol Infect Dis; 2016 Oct 15; 86(2):224-30. PubMed ID: 27498610 [Abstract] [Full Text] [Related]
11. Characterization of Streptococcus pneumoniae clones from paediatric patients with cystic fibrosis. Pimentel de Araujo F, D'Ambrosio F, Camilli R, Fiscarelli E, Di Bonaventura G, Baldassarri L, Visca P, Pantosti A, Gherardi G. J Med Microbiol; 2014 Dec 15; 63(Pt 12):1704-1715. PubMed ID: 25301526 [Abstract] [Full Text] [Related]
12. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. Moore MR, Gertz RE, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B. J Infect Dis; 2008 Apr 01; 197(7):1016-27. PubMed ID: 18419539 [Abstract] [Full Text] [Related]
13. Serological and molecular capsular typing, antibiotic susceptibility and multilocus sequence typing of Streptococcus pneumoniae isolates from invasive and non-invasive infections. Zhang YJ, Chen YS, Wang ZW, Li YQ, Wang DX, Shang Y, Fu RR, Hu YH, Geng R, Wei LP, Yang JP, Li JS, Yu Q, DU J, Gao ZC. Chin Med J (Engl); 2013 Jun 01; 126(12):2296-303. PubMed ID: 23786942 [Abstract] [Full Text] [Related]
14. Decreased Carriage and Genetic Shifts in the Streptococcus pneumoniae Population After Changing the Seven-valent to the Thirteen-valent Pneumococcal Vaccine in Norway. Steens A, Caugant DA, Aaberge IS, Vestrheim DF. Pediatr Infect Dis J; 2015 Aug 01; 34(8):875-83. PubMed ID: 26020410 [Abstract] [Full Text] [Related]
15. Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, Spain. Ardanuy C, de la Campa AG, García E, Fenoll A, Calatayud L, Cercenado E, Pérez-Trallero E, Bouza E, Liñares J. Emerg Infect Dis; 2014 Nov 01; 20(11):1848-56. PubMed ID: 25340616 [Abstract] [Full Text] [Related]
16. Impact of the Seven-valent Pneumococcal Conjugate Vaccine on Acute Otitis Media in Japanese Children: Emergence of Serotype 15A Multidrug-resistant Streptococcus pneumoniae in Middle Ear Fluid Isolates. Ozawa D, Yano H, Endo S, Hidaka H, Kakuta R, Okitsu N, Kanamori H, Ogawa M, Ichimura S, Shimojima M, Inomata S, Kaku M, Katori Y. Pediatr Infect Dis J; 2015 Sep 01; 34(9):e217-21. PubMed ID: 26083590 [Abstract] [Full Text] [Related]
17. Prevalence and characteristics of Streptococcus pneumoniae "putative serotype 6E" isolates from Asian countries. Baek JY, Park IH, So TM, Lalitha MK, Shimono N, Yasin RM, Carlos CC, Perera J, Thamlikitkul V, Hsueh PR, Van PH, Shibl AM, Song JH, Ko KS. Diagn Microbiol Infect Dis; 2014 Dec 01; 80(4):334-7. PubMed ID: 25439447 [Abstract] [Full Text] [Related]
18. Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018. Golden AR, Fear T, Baxter M, Adam HJ, Martin I, Demczuk W, Karlowsky JA, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA). Diagn Microbiol Infect Dis; 2021 Oct 01; 101(2):115447. PubMed ID: 34192638 [Abstract] [Full Text] [Related]
19. Global Distribution of Invasive Serotype 35D Streptococcus pneumoniae Isolates following Introduction of 13-Valent Pneumococcal Conjugate Vaccine. Lo SW, Gladstone RA, van Tonder AJ, Hawkins PA, Kwambana-Adams B, Cornick JE, Madhi SA, Nzenze SA, du Plessis M, Kandasamy R, Carter PE, Eser ÖK, Ho PL, Elmdaghri N, Shakoor S, Clarke SC, Antonio M, Everett DB, von Gottberg A, Klugman KP, McGee L, Breiman RF, Bentley SD. J Clin Microbiol; 2018 Jul 01; 56(7):. PubMed ID: 29720431 [Abstract] [Full Text] [Related]
20. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA). Shibl AM, Memish ZA, Al-Kattan KM. Vaccine; 2012 Dec 31; 30 Suppl 6():G32-6. PubMed ID: 23228355 [Abstract] [Full Text] [Related] Page: [Next] [New Search]